SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: nigel bates who wrote (414)10/21/2003 7:41:15 PM
From: SemiBull   of 415
 
Essential Therapeutics Announces the Effectiveness of its Plan of Reorganization

Tuesday October 21, 4:28 pm ET

WALTHAM, Mass., Oct. 21 /PRNewswire/ -- Essential Therapeutics, Inc., and its subsidiaries, Maret Corporation and The Althexis Company, Inc., today announced that their Plan of Reorganization filed with the Delaware Bankruptcy Court on May 2, 2003 was confirmed by the Bankruptcy Court on October 10, 2003 and has become effective. Among other things, the Plan provides for the merger of Maret and Althexis into Essential, the payment in full of obligations owed to certain creditors and the recapitalization of the company as a privately-held entity.

Source: Essential Therapeutics, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext